Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
AbbVie, adalimumab, adaptive, ahead, aimed, angina, apotex, ASCO, ASN, ATRA, Avastin, Balachandran, balugrastim, BCA, belonging, BESP, bioequivalence, biopharmaceutical, BP, brodalumab, Carolina, CaSR, Celltech, cheaper, cholesterol, clarifying, cognitive, College, commentary, confronted, counterfeit, counterfeiting, curbing, cyber, Cynthia, DC, deCODE, destruction, devote, Durgin, eckert, engineering, exacting, extracellular, familial, fatal, flexibility, footprint, foster, frame, Freeman, GCTB, German, glycine, great, greatly, guilty, Hood, HUMIRA, hyperlipidemia, hypersensitivity, incentivized, infarction, infliximab, Inspector, intrusion, IQWiG, irreversible, ixekizumab, KAI, Kenneth, landscape, Latin, leader, Leroy, linked, LP, Madhavan, Madhu, minimal, minimize, misbranding, misdemeanor, MN, multitude, Mustafa, Neupeg, Nevzat, NHL, NOL, outlicensing, page, passage, Patton, pedigree, Pharma, pioneer, plea, Poland, preexisting, prepaid, privacy, prolonged, prominence, Purnell, rare, redemption, Reed, regularly, relapsed, REMICADE, repeal, replenished, requisite, residential, rituximab, romosozumab, Rosenblum, ROW, SCAN, schizophrenia, spur, statin, stolen, stored, strength, sum, supplementary, surface, surrogate, Taxpayer, theft, tibia, today, TPE, transit, transition, transitioning, trastuzumab, trebananib, Turkey, Tyler, ulcerative, unanticipated, unavailable, unbilled, undiscounted, unlawfully, unsafe, unstable, vertebral, vitro, withholding, worsening, Xeljanz
Removed:
accompanied, Advisor, ALJ, Alliance, alternatively, amounting, amplify, Anna, anticipation, arm, asLarson, assert, asserting, attracting, awarded, AWP, backed, background, Baxter, bear, Behring, Beier, bill, biology, BioScience, Bonanni, broadly, captionedIn, captionedLarson, carboplatin, cellular, Chevron, collective, column, comment, concentrate, Constance, constitute, consumer, contractility, convict, counted, Cytyc, Daiichi, Dear, deceptive, dermatology, detailed, Dey, diphosphate, discontinue, dispensing, dissemination, Electric, elevating, enforceable, England, entitledThe, EPO, estimable, exemption, exercising, Fabrizio, falsely, forfeiture, FOSAMAX, Fujisawa, furnish, Gensia, geographical, GRANULOKINE, Grumman, guideline, half, Hartson, hazard, head, hematocrit, hereto, Hoechst, Hogan, holding, House, hypocalcemia, Ilypsa, inhibit, initiating, innovating, inRosenblum, instruction, interval, ischemia, ITC, Journal, Justice, locally, Marion, MCI, MDL, Mellon, modality, Mountain, neck, Northern, Northrop, notified, OCI, ofDurgin, ofRosenblum, ONJ, opposing, opposition, paclitaxel, pancreatic, pediatric, peg, penetration, Pharmacia, Pharmacopoeia, Philadelphia, predominately, proceed, proceeding, quickly, registry, rehearing, reimburse, resolving, restructure, retaining, rheumatology, Richo, Roussel, Sandoz, Sankyo, satisfied, secreted, secretion, selectively, SF, spent, stipulated, studied, suited, suspended, tentative, terminating, territory, Tevagrastim, theIn, Thompson, timetable, tissue, titledBirch, track, training, trustee, Turner, undetermined, unlawful, unusual, Upjohn, vacated, violating, vision, weighting, Welfare, withdrew, yearly, ZLB
Filing tables
Filing exhibits
- 10-K Annual report
- 3.5 Charter Certificate
- 10.4 Amended Performance Award Program
- 10.6 Amended and Restated Director Program
- 10.8 Form of Restricted Stock Unit Agreement for Director Program
- 10.17 First Amendment to the Executive Incentive Plan
- 10.51 Amendment 1 to License Agreement
- 10.52 Amendment 2 to License Agreement
- 10.54 Collaboration and License Agreement and Amendment 1
- 10.58 Amendment 1 to Collaboration Agreement
- 10.61 Amendment 2 to Expansion Agreement
- 10.63 Amendment 1 to Sourcing and Supply Agreement
- 21 Subsidiaries of the Company
- 31 Rule 13A-14(A) Certifications
- 32 Section 1350 Certifications
Related press release
AMGN similar filings
Filing view
External links